Alamar Biosciences Says Emory Study Using Its NULISA Platform Found Blood Protein Signature Identifying ALS With 98.3% Balanced Accuracy, Not A Clinical Test

뉴스 본문을 불러오고 있어요.

Alamar Biosciences Says Emory Study Using Its NULISA Platform Found Blood Protein Signature Identifying ALS With 98.3% Balanced Accuracy, Not A Clinical Test | 웨이프 WAPE

Alamar Biosciences Says Emory Study Using Its NULISA Platform Found Blood Protein Signature Identifying ALS With 98.3% Balanced Accuracy, Not A Clinical Test

기사 요약

관련 종목

댓글 —